Core Viewpoint - Huakang Clean achieved significant revenue growth and profitability in the first nine months of 2025, indicating strong business performance in the medical purification sector [2]. Group 1: Financial Performance - For the period from January to September 2025, Huakang Clean reported operating revenue of 1.431 billion yuan, representing a year-on-year increase of 32.59% [2]. - The net profit attributable to the parent company reached 61.1567 million yuan, showing a substantial year-on-year growth of 211.46% [2]. Group 2: Shareholder and Market Activity - As of October 31, 2025, the number of Huakang Clean's shareholders increased to 10,600, up by 2.43% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 2.37% to 6,845 shares [2]. - On November 6, 2025, Huakang Clean's stock price rose by 0.40%, with a trading volume of 55.2064 million yuan [1]. Group 3: Financing and Margin Trading - On November 6, 2025, Huakang Clean had a financing buy-in amount of 6.5431 million yuan, while the financing repayment was 9.0856 million yuan, resulting in a net financing buy of -2.5425 million yuan [1]. - The total margin trading balance for Huakang Clean reached 98.7520 million yuan, accounting for 3.05% of its market capitalization, which is above the 90th percentile of the past year [1]. - There were no shares sold or repaid in the securities lending market on November 6, 2025, with the securities lending balance also at zero, indicating a high level of inactivity in this area [1]. Group 4: Dividend Distribution - Huakang Clean has distributed a total of 40.0214 million yuan in dividends since its A-share listing, with 29.4614 million yuan distributed over the past three years [3]. Group 5: Institutional Holdings - As of September 30, 2025, new institutional shareholders include Fortune Optimized Enhanced Bond A/B and Fortune Jiuli Steady Configuration Mixed A, which are now among the top ten circulating shareholders [3].
华康洁净11月6日获融资买入654.31万元，融资余额9875.20万元